What does CUSIP 29970R105 represent in this 13F holders report?

CUSIP 29970R105 is the security identifier for EVAX - EVAXION BIOTECH A S - ADS used to aggregate holder disclosures.

How many institutions held EVAX - EVAXION BIOTECH A S - ADS in Q3 2021?

7 institutional investors reported EVAX - EVAXION BIOTECH A S - ADS for Q3 2021. Use the holders table for investor-level position and value details.

EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class: Equity / ADS
Total 13F shares: 340,282
Total 13F value: $3,279,000
Share change: -99,271
SEC-reported price per share: $9.65
Number of holders: 7
Value change: -$733,210
Number of buys: 4
Number of sells: 3

Security key

29970R105

Report period

Q3 2021

Institutions

Top holders

EVAX full security history Ownership snapshot Full 13F holder table Evaxion A/S SEC filings Evaxion A/S company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of EVAX - EVAXION BIOTECH A S - ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Maven Securities LTD

Disclosed value leader

Maven Securities LTD

Comparable rows

0/6

Latest evidence

30 Jun 2021

13F Highest disclosed value: $1,760,000 6 rows are not safely comparable across share classes.

Quick read

Maven Securities LTD has the largest disclosed position value at $1.76M.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Maven Securities LTD's linked filing trail.

Disclosed position value Top 5

Maven Securities LTD $1.76M

Granite Point Capital Management,... $911K

Telemetry Investments, L.L.C. $315K

Kepos Capital LP $287K

ETF MANAGERS GROUP, LLC $43K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Maven Securities LTD	13F Company 13F	— denominator unverified	$1,760,000 235,606 shares	—	30 Jun 2021
Granite Point Capital Management, L.P.	13F Company 13F	— denominator unverified	$911,000 117,690 shares	—	30 Jun 2021
Telemetry Investments, L.L.C.	13F Company 13F	— denominator unverified	$315,000 41,729 shares	—	30 Jun 2021
Kepos Capital LP	13F Company 13F	— denominator unverified	$287,000 37,098 shares	—	30 Jun 2021
ETF MANAGERS GROUP, LLC	13F Company 13F	— denominator unverified	$43,000 5,662 shares	—	30 Jun 2021
UBS Group AG	13F Company 13F	— denominator unverified	$14,000 1,768 shares	—	30 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

340,282

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 value	Q3 2021 value	Value change	Value Chg %